These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8767845)

  • 1. Synthesis and antirhinovirus activity of 3-(diethylamino)-5-phenylisoxazole derivatives.
    Mazzei M; Garzoglio R; Balbi A; Grandi T; De Montis A; Corrias S; La Colla P
    Farmaco; 1996 May; 51(5):351-9. PubMed ID: 8767845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antirhinovirus activity of new 3-benzyl chromene and chroman derivatives.
    Conti C; Desideri N
    Bioorg Med Chem; 2009 May; 17(10):3720-7. PubMed ID: 19398344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition of human rhinovirus 2 and coxsackievirus B3 replication.
    Makarov VA; Riabova OB; Granik VG; Wutzler P; Schmidtke M
    J Antimicrob Chemother; 2005 Apr; 55(4):483-8. PubMed ID: 15743897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative structure-activity relationship studies of [(biphenyloxy)propyl]isoxazole derivatives. Inhibitors of human rhinovirus 2 replication.
    Kuz'min VE; Artemenko AG; Muratov EN; Volineckaya IL; Makarov VA; Riabova OB; Wutzler P; Schmidtke M
    J Med Chem; 2007 Aug; 50(17):4205-13. PubMed ID: 17665898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14.
    Oren DA; Zhang A; Nesvadba H; Rosenwirth B; Arnold E
    J Mol Biol; 1996 May; 259(1):120-34. PubMed ID: 8648640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disoxaril-related 3-(diethylamino)-5-phenylisoxazoles.
    Mazzei M; Dondero R; Ledda B; Demontis F; Vargiu L
    Farmaco; 2000 Feb; 55(2):119-24. PubMed ID: 10782382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of orobol 7-O-D-glucoside from banaba (Lagerstroemia speciosa L.) on human rhinoviruses replication.
    Choi HJ; Bae EY; Song JH; Baek SH; Kwon DH
    Lett Appl Microbiol; 2010 Jul; 51(1):1-5. PubMed ID: 20497313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Amino-3-substituted-6-[(E)-1-phenyl-2-(N-methylcarbamoyl)vinyl]imid azo[1,2-a]pyridines as a novel class of inhibitors of human rhinovirus: stereospecific synthesis and antiviral activity.
    Hamdouchi C; de Blas J; del Prado M; Gruber J; Heinz BA; Vance L
    J Med Chem; 1999 Jan; 42(1):50-9. PubMed ID: 9888832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication.
    Kong JS; Venkatraman S; Furness K; Nimkar S; Shepherd TA; Wang QM; Aubé J; Hanzlik RP
    J Med Chem; 1998 Jul; 41(14):2579-87. PubMed ID: 9651162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and in vitro evaluation of novel chroman-4-one, chroman, and 2H-chromene derivatives as human rhinovirus capsid-binding inhibitors.
    Conti C; Proietti Monaco L; Desideri N
    Bioorg Med Chem; 2011 Dec; 19(24):7357-64. PubMed ID: 22088306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [[[(Thienylcarbonyl)alkyl]oxy]phenyl]- and [[[(pyrrylcarbonyl)alkyl]oxy]phenyl]oxazoline derivatives with potent and selective antihuman rhinovirus activity.
    Massa S; Corelli F; Artico M; Mai A; Ragno R; De Montis A; Loi AG; Corrias S; Marongiu ME; La Colla P
    J Med Chem; 1995 Mar; 38(5):803-9. PubMed ID: 7877145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antirhinoviral activity of heterocyclic analogs of Win 54954.
    Bailey TR; Diana GD; Kowalczyk PJ; Akullian V; Eissenstat MA; Cutcliffe D; Mallamo JP; Carabateas PM; Pevear DC
    J Med Chem; 1992 Nov; 35(24):4628-33. PubMed ID: 1335079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies on the antirhinovirus activity and the mode of action of the rhinovirus capsid binding agents, chalcone amides.
    Ninomiya Y; Shimma N; Ishitsuka H
    Antiviral Res; 1990 Feb; 13(2):61-74. PubMed ID: 2160796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors.
    Fan SY; Zheng ZB; Mi CL; Zhou XB; Yan H; Gong ZH; Li S
    Bioorg Med Chem; 2009 Jan; 17(2):621-4. PubMed ID: 19091578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a high-throughput human rhinovirus infectivity cell-based assay for identifying antiviral compounds.
    Phillips T; Jenkinson L; McCrae C; Thong B; Unitt J
    J Virol Methods; 2011 May; 173(2):182-8. PubMed ID: 21300110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enatioseparation and anti-rhinovirus activity of 3-benzylchroman-4-ones.
    Quaglia MG; Desideri N; Bossu E; Sgro R; Conti C
    Chirality; 1999; 11(5-6):495-500. PubMed ID: 10419285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anti-rhinovirus activity of 2-styrylchromones.
    Desideri N; Conti C; Mastromarino P; Mastropaolo F
    Antivir Chem Chemother; 2000 Nov; 11(6):373-81. PubMed ID: 11227995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anti-HIV-1 activity of N-hydroxy-N1-aminoguanidines.
    Doubell PC; Oliver DW
    Arzneimittelforschung; 1992 Jan; 42(1):65-9. PubMed ID: 1586383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-rhinovirus-specific activity of the alpha-sympathomimetic oxymetazoline.
    Koelsch S; Tschaikin M; Sacher F
    Arzneimittelforschung; 2007; 57(7):475-82. PubMed ID: 17803062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 'new' generation of more potent synthetic antirhinovirus compounds: comparison of their MICs and their synergistic interactions.
    Al-Nakib W; Tyrrell DA
    Antiviral Res; 1987 Nov; 8(4):179-87. PubMed ID: 2833156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.